Clinical experience with silver oxide-containing hydroxyapatite coated spinal interbody implant : prospective multicenter study

Clinical experience with silver oxide-containing hydroxyapatite coated spinal interbody implant : prospective multicenter study - Ag-HA spinal cage clinical experience: prospective multicenter study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039964

Enrollment

250

Registered

2020-04-01

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar degenerative disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: lumbar degenerative disease

Exclusion criteria

Exclusion criteria: prior lumbar surgery

Design outcomes

Primary

Measure	Time frame
bone fusion rate(6month, 1 ,2 year)	—

Secondary

Measure	Time frame
adverse events(infection rate, implant loosening, argria)	—

Countries

Japan

Contacts

Public Contacttadatsugu morimoto

Saga university Department of orhtopedics surgery

morimot3@cc.saga-u.ac.jp0952342343

Outcome results